FDA.reportPublic FDA data

Application 079141

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOLTERODINE TARTRATETOLTERODINE TARTRATECAPSULE, EXTENDED RELEASE;ORAL2MGNoNo
002TOLTERODINE TARTRATETOLTERODINE TARTRATECAPSULE, EXTENDED RELEASE;ORAL4MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7163Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-7164Tolterodine TartrateTolterodine TartrateTeva Pharmaceuticals USA, Inc.ANDACurrent
50090-3475Tolterodine TartrateTolterodine TartrateA-S Medication SolutionsANDACurrent
50090-3475Tolterodine TartrateTolterodine TartrateA-S Medication SolutionsANDACurrent
50090-3475Tolterodine TartrateTolterodine TartrateA-S Medication SolutionsANDACurrent
50090-5995Tolterodine TartrateTolterodine TartrateA-S Medication SolutionsANDACurrent